Trexquant Investment’s Immunocore IMCR Stock Holding History

Trexquant Investment’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$624K	Buy	+20,685	New	+$669K	﹤0.01%	1398
2025 Q4	–	Sell	-100,580	Closed	-$3.65M	–	1746
2025 Q3	$3.65M	Buy	100,580 +81,291	+421%	+$2.76M	0.04%	669
2025 Q2	$605K	Buy	+19,289	New	+$599K	0.01%	1212
2024 Q1	–	Sell	-28,545	Closed	-$1.95M	–	1589
2023 Q4	$1.95M	Buy	28,545 +1,746	+7%	+$90.8K	0.04%	558
2023 Q3	$1.39M	Buy	26,799 +18,768	+234%	+$1.11M	0.03%	625
2023 Q2	$482K	Sell	8,031 -29,213	-78%	-$1.67M	0.01%	1020
2023 Q1	$1.84M	Buy	37,244 +20,992	+129%	+$1.18M	0.05%	488
2022 Q4	$928K	Buy	+16,252	New	+$915K	0.03%	673

Other funds holding IMCR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Trexquant Investment's IMCR Position: Q1 2026 in Review

Trexquant Investment opened a new position in Immunocore (IMCR) in Q1 2026: 20,685 shares worth $624K. The stake represents ﹤0.01% of the portfolio and ranks #1398 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in IMCR as recently as Q3 2025.

Trexquant Investment first reported a position in IMCR in Q4 2022 and has held it in 8 quarters since. The position peaked at $3.65M in Q3 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

Trexquant Investment held 20,685 shares of Immunocore worth $624K as of Q1 2026.
Immunocore was a new Trexquant Investment position in Q1 2026.
Immunocore made up ﹤0.01% of Trexquant Investment's portfolio in Q1 2026, its #1398 holding.
Trexquant Investment first reported a position in Immunocore in Q4 2022 and has held it in 8 quarters since.
Trexquant Investment's Immunocore position peaked at $3.65M in Q3 2025.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.